EP0580752A4 - Human bone derived insulin like growth factor binding protein - Google Patents

Human bone derived insulin like growth factor binding protein

Info

Publication number
EP0580752A4
EP0580752A4 EP9292910967A EP92910967A EP0580752A4 EP 0580752 A4 EP0580752 A4 EP 0580752A4 EP 9292910967 A EP9292910967 A EP 9292910967A EP 92910967 A EP92910967 A EP 92910967A EP 0580752 A4 EP0580752 A4 EP 0580752A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
binding protein
factor binding
human bone
bone derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP9292910967A
Other versions
EP0580752A1 (en
Inventor
Mannheim Gmbh Boehringer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of EP0580752A1 publication Critical patent/EP0580752A1/en
Publication of EP0580752A4 publication Critical patent/EP0580752A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP9292910967A 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein Withdrawn EP0580752A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68835391A 1991-04-19 1991-04-19
US688353 1991-04-19

Publications (2)

Publication Number Publication Date
EP0580752A1 EP0580752A1 (en) 1994-02-02
EP0580752A4 true EP0580752A4 (en) 1994-08-24

Family

ID=24764088

Family Applications (1)

Application Number Title Priority Date Filing Date
EP9292910967A Withdrawn EP0580752A4 (en) 1991-04-19 1992-04-15 Human bone derived insulin like growth factor binding protein

Country Status (11)

Country Link
EP (1) EP0580752A4 (en)
JP (1) JP2527896B2 (en)
KR (1) KR0129864B1 (en)
AU (1) AU658187B2 (en)
CA (1) CA2107475A1 (en)
CZ (1) CZ283601B6 (en)
FI (1) FI934588A (en)
HU (1) HUT70297A (en)
NO (1) NO933742L (en)
RU (1) RU2114120C1 (en)
WO (1) WO1992018154A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233155T2 (en) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6124259A (en) * 1993-01-28 2000-09-26 Celtrix Pharmaceuticals, Inc. Method for treating ophthalmic disorders with IGFBP
EP0800530A4 (en) * 1994-07-20 1998-12-02 Celtrix Pharma Igf/igfbp complex for promoting bone formation and for regulating bone remodeling
DE69637332T2 (en) 1995-10-11 2008-10-09 Novartis Vaccines and Diagnostics, Inc., Emeryville Combination of PDGF, KGF, IGF and IGFBP for wound healing
PL228041B1 (en) 2001-01-05 2018-02-28 Amgen Fremont Inc Antibody against the receptor of insulin-like growth factor I, pharmaceutical composition containing it, method for producing it, applications, cell line, isolated molecule of nucleic acid, vector, host cell and transgenic animal
US10212614B2 (en) * 2015-12-31 2019-02-19 Facebook, Inc. Igniting network nodes in a multi-hop wireless network
EP3397644A4 (en) * 2015-12-31 2018-12-19 Siemens Healthcare Diagnostics Inc. Non-recombinant human insulin-like growth factor binding protein concentrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7907958A (en) * 1979-10-30 1981-06-01 Wijn Adriaan Jacques De CART OR FRAME FITTED WITH FOLDING WHEELS.
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
EP0289314B1 (en) * 1987-04-28 1994-10-12 Roche Diagnostics GmbH Use of IGF-II in the treatment of bone disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDRESS, D. L. ET AL.: "A novel human insulin-like growth factor binding protein secreted by osteoblast-like cells", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 176, no. 1, 15 April 1991 (1991-04-15), DULUTH, MINNESOTA US, pages 213 - 218 *
BAUTISTA, C. M. ET AL.: "Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential canditate for fixing IGF-II in human bone", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 176, no. 2, 30 April 1991 (1991-04-30), DULUTH, MINNESOTA US, pages 756 - 763 *
See also references of WO9218154A1 *

Also Published As

Publication number Publication date
CA2107475A1 (en) 1992-10-20
FI934588A0 (en) 1993-10-18
RU2114120C1 (en) 1998-06-27
JPH06501270A (en) 1994-02-10
NO933742L (en) 1993-10-18
CZ219093A3 (en) 1994-12-15
AU1784492A (en) 1992-11-17
JP2527896B2 (en) 1996-08-28
AU658187B2 (en) 1995-04-06
WO1992018154A1 (en) 1992-10-29
HU9302942D0 (en) 1994-01-28
HUT70297A (en) 1995-09-28
EP0580752A1 (en) 1994-02-02
KR0129864B1 (en) 1998-04-09
FI934588A (en) 1993-10-18
CZ283601B6 (en) 1998-05-13

Similar Documents

Publication Publication Date Title
EP0348581A3 (en) Vertebrae fixation implant
NZ283716A (en) Bone growth stimulating factor
EP0517030A3 (en) Vertebral implant
EP0741578A4 (en) Human growth hormone
GB2251795B (en) Orthopaedic implant
EP0871705A4 (en) Human ccn-like growth factor
AU8098091A (en) Artificial vertebra
EP0550771A4 (en) Immunoglobulin-combining artificial protein
IL106278A0 (en) Bone formation-inducing protein
GB2257611B (en) Improvements in surgical slippers for animals
EP0929575A4 (en) Novel human growth factors
GB9020035D0 (en) Bone implant
EP0552474A3 (en) Artificial blood vessel
EP0580752A4 (en) Human bone derived insulin like growth factor binding protein
EP0728142A4 (en) Novel antler-derived bone growth factors
GB8807026D0 (en) Bone fixation
EP0796325A4 (en) Human vascular ibp-like growth factor
AU7301891A (en) Bone fixation
EP0494369A3 (en) Sterilization of growth factors
GB9411243D0 (en) Unguinol and analogs are animal growth permittants
EP0540575A4 (en) Human meg-csf protein and methods
GB2268409B (en) Bone implant
IE892936L (en) Human/bovine basic growth factor
IE891099L (en) Protein which induces bone growth
GB9209198D0 (en) Bone growth stimulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930903

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

RHK1 Main classification (correction)

Ipc: C07K 15/06

A4 Supplementary search report drawn up and despatched

Effective date: 19940705

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19980505

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ROCHE DIAGNOSTICS GMBH

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19990914